On Monday, Hologic Inc HOLX agreed to acquire Gynesonics, Inc. for approximately $350 million. Gynesonics is a privately held medical device company that develops minimally invasive solutions for women's health. California-based Gynesonics develops and sells the Sonata System, a technology intended for diagnostic intrauterine imaging and transcervical treatment of certain symptomatic uterine fibroids, including those associated with heavy menstrual bleeding. The Sonata System combines real-time intrauterine ...

Hologic, Inc. (HOLX) entered the Breast Cancer Awareness Month by ringing the Nasdaq opening bell for the 18th year. As part of this annual tradition, Hologic launched a comprehensive patient education campaign named BustTheMyth. The campaign is aimed at dispelling myths about breast cancer, mammograms and breast density. The latest announcement highlights Hologic's commitment to advancing technology and improving patient outcomes across the continuum of breast health. Significance of Hologic's BustTheMyth ...

October is celebrated as breast cancer awareness month annually, and Hologic (HOLX) , this time too, honored the occasion by ringing the Nasdaq opening bell for the 18 consecutive time. While celebrating this yearly tradition, the company came into the limelight as it also introduced a comprehensive education campaign aimed at debunking common myths about breast cancer, mammograms and breast density. Aptly named #BustTheMyth, the program stresses the need for practical education alongside cutting-edge techn ...

The most recent trading session ended with Hologic (HOLX) standing at $80.26, reflecting a +0.48% shift from the previouse trading day's closing. This move lagged the S&P 500's daily gain of 0.97%. At the same time, the Dow added 0.3%, and the tech-heavy Nasdaq gained 1.45%. The medical device maker's stock has dropped by 3.4% in the past month, exceeding the Medical sector's loss of 3.72% and lagging the S&P 500's gain of 5.41%. Market participants will be closely following the financial results of Hologic ...

Hologic (HOLX) has been gaining from new strategic product launches across Diagnostics and Breast Health. However, macroeconomic issues and unfavorable FX headwinds continue to impede growth. The stock carries a Zacks Rank #3 (Hold) currently. Major Factors Driving HOLX Stock Growth Among Hologic's advanced diagnostic products, primary revenue-generating ones are molecular diagnostic assays, which run on advanced instrumentation systems (Panther, Panther Fusion and Tigris), ThinPrep cytology system and the ...

Hologic, Inc.'s (HOLX) sustained momentum in the Molecular Diagnostics portfolio is poised to fuel its growth in the upcoming quarters. A crucial part of its long-term strategy, the company is planning to expand into more countries overseas, which are largely untapped. It is also using its strong cash position strategically by focusing on acquisitions and share buybacks. Meanwhile, concerns remain over the impact of macroeconomic challenges on Hologic's operations. Adverse currency impact also adds to the w ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both. Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor. It also includes access to the Zacks Style Scores. What are ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed ...

Shares of Hologic (HOLX) are showing impressive gains of late, trading quite near its 52-week high of $84.67. The stock closed Thursday at $80.99, just 4.3% below the highest point. In the past three months, the women's health company's stocks have gained 8.5%, surpassing the industry's growth of 2% and the S&P 500's return of 2.8%. Hologic has also performed better than the industry rivals QIAGEN (QGEN) and Becton, Dickinson and Company (BDX) . Image Source: Zacks Investment Research 3-Months Performance T ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens. Zacks Premium also includes the Zacks Style Scores. What are the Zacks Style Scores? Developed al ...